C12N 2800/60
Vectors containing traps for
Official title: Vectors containing traps for, e.g. exons, promoters
C12N2800/60 (Vectors containing traps for) appears on 93 US grants and 112 published applications in this corpus.
Search patents in C12N- Granted patents
- 93
- Published applications
- 112
- Assignees
- 87
- Inventors
- 285
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 11 | 0 |
| 2001 | 5 | 0 |
| 2002 | 7 | 6 |
| 2003 | 6 | 14 |
| 2004 | 4 | 13 |
| 2005 | 2 | 12 |
| 2006 | 4 | 5 |
| 2007 | 1 | 5 |
| 2008 | 6 | 5 |
| 2009 | 4 | 4 |
| 2010 | 6 | 3 |
| 2011 | 1 | 3 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 4 | 3 |
| 2016 | 1 | 2 |
| 2017 | 2 | 0 |
| 2018 | 0 | 4 |
| 2019 | 3 | 4 |
| 2020 | 4 | 3 |
| 2021 | 1 | 4 |
| 2022 | 2 | 3 |
| 2023 | 4 | 4 |
| 2024 | 1 | 9 |
| 2025 | 5 | 0 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Promoter and use thereof15 Sep 2026US 12,735,715 B2Cj Cheiljedang Corporation
- Compositions and methods for mammalian genetics and uses thereof17 Mar 2026US 12,577,587 B2Whitehead Institute for Biomedical Research
- Promoter and carrier composed of same and application thereof9 Dec 2025US 12,492,405 B2Azenta US, Inc.
- Methods for modifying a genome18 Nov 2025US 12,473,574 B2Regeneron Pharmaceuticals, Inc.
- Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene21 Oct 2025US 12,448,613 B2Precision BioSciences, Inc.
- Genetically-modified t cells comprising a modified intron in the t cell receptor alpha gene8 Oct 2026US 2026/0308549 A1Precision BioSciences, Inc.
- Circular rna vectors comprising modified nucleotides20 Aug 2026US 2026/0242805 A1University of Massachusetts
- Methods for modifying a genome13 Aug 2026US 2026/0234672 A1Regeneron Pharmaceuticals, Inc.
- Compositions useful in treatment of cdkl5 deficiency disorder (cdd)26 Dec 2024US 2024/0425882 A1The Trustees of the University of Pennsylvania
- Differential proliferation of human hematopoietic stem and progenitor cells using truncated erythropoietin receptors12 Dec 2024US 2024/0409958 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents
- Deoxyribonucleic acid segment from a virus193US 4,968,615 ACiba-Geigy Corporation · 1990
- Mammalian viral vectors and their uses80US 6,255,071 B1Cold Spring Harbor Laboratory · 2001
- Indexed library of cells containing genomic modifications and methods of making and utilizing the same78US 6,136,566 ALexicon Graphics Incorporated · 2000
- Vectors for gene trapping and gene activation67US 6,080,576 ALexicon Genetics Incorporated · 2000
- Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell63US 7,160,682 B2Regents of the University of Minnesota · 2007